YiDing Yu – Twiage
Category: Resident
Twiage is a secure mobile app-to-web platform that allows medics to send real-time data in the field to doctors in the ED. The communication between EMS and ED is currently carried about by a one-time radio communication. This often leaves ED physicians
in a black box until the patient arrives and delays mobilization of resources, which can have devastating consequences in an acute MI, stroke, or major trauma. By sending real-time information available on a web dashboard in the ED, Twiage saves time,
improves provider communication, allows the early mobilization of resources, and improves EMS and ED workflow to help deliver better patient care.
Jasmine Thum – Brain monitoring technology for pediatric populations
Category: Student
Morbidity and mortality are still significant problems in general anesthesia (GA) and are addressed frequently both clinically and in the popular media. In very young patients evidence suggests that neurotoxicity causes adverse neuro-cognitive effects
and also poses a major health concern following GA. However there is limited understanding of the fundamental brain mechanisms underlying anesthetic drugs. While it is known that general anesthetics primarily target the central nervous system (CNS),
standards of clinical care for brain monitoring have yet to be established. This highlights an urgent need for improved understanding of brain physiology under GA, especially in the vulnerable pediatric population. Studies have shown the potential
for electroencephalography (EEG)-based brain monitors to reduce over-exposure to anesthetics. Unfortunately though, for unknown reasons these existing index-based clinical EEG monitors (which provide a single proprietary number indicating depth of
patient unconsciousness) do not work in children.
We found a constant spectral anesthetic signature that emerged from these signals, regardless of age. This forms the basis of a novel technology for brain monitoring that could be applied to pediatric populations to replace current inaccurate methods.
Continued analysis on >70 additional patients is currently underway, and similar results will contribute to the enormous impact that this new technology and appropriate monitoring paradigm will have on daily clinical practice with similar ease of
use and far more cost effectiveness due to decreased patient morbidity and mortality resulting from neurotoxicity.
